Newswire

iPhone App for Abbott's FreeStyle Libre Flash Glucose Monitoring System Makes Diabetes Management Easier and More Convenient for Canadians

MISSISSAUGA, Ontario, Oct. 4, 2018 /CNW/ -- Abbott (NYSE: ABT) announced today the company has received the Health Canada license of its FreeStyle LibreLink mobile app for use with compatible iOS ...
MobiHealthNews

With new FDA clearance, Abbott Freestyle Libre users can ditch handheld readers for an app

Just a short while after securing a CE Mark for its second generation device, Abbott has been granted FDA clearance for FreeStyle LibreLink, a companion mobile app for its 10 to 14-day CGM. The launch ...
Monthly Prescribing Reference

FDA Clears FreeStyle Libre 2 App to Monitor Glucose Levels

The Food and Drug Administration (FDA) has cleared the FreeStyle ® Libre 2 iOS App for use with the FreeStyle Libre 2 14-day glucose sensors in individuals 4 years of age and older with diabetes. The ...
Nasdaq

FDA Clears Abbott's FreeStyle Libre 2 IOS App For Diabetes Management

(RTTNews) - Abbott said that the U.S. Food and Drug Administration has cleared the FreeStyle Libre 2 iOS application for use with compatible iPhones, providing a comprehensive digital offering for its ...
AppleInsider

Glucose monitoring app glitch exposes vulnerabilities in digital health tools

Some users in the UK are experiencing a disruption in the functionality of the FreeStyle Libre 2 blood sugar monitoring app following an update, and it underscores the vulnerability of our digital ...